Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine whether deferoxamine and xingnaojing injection
is effective and safe as a treatment for intracerebral hemorrhage.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Capital Medical University
Collaborators:
Beijing Aerospace General Hospital Beijing Ditan Hospital Beijing Fangshan District Liangxiang Hospital Beijing Haidian Hospital Beijing Jishuitan Hospital Beijing Luhe Hospital Beijing Neurosurgical Institute Beijing Pinggu District Hospital Beijing Shuyi Hospital Beijing Tiantan Hospital Beijing Youyi Hospital Chinese PLA General Hospital General Hospital of Beijing PLA Military Region Peking University First Hospital Peking University People's Hospital Peking University Third Hospital People's Hospital of Beijing Daxing District People’s Hospital of Beijing Daxing District The 263 Hospital of PLA The Second Artillery General Hospital Xiyuan Hospital of China Academy of Chinese Medical Sciences